The use of primaquine as a gametocidal agent is also limited due to the risk of hemolysis with prolonged administration in patients with a significant enzymatic deficiency of glucose-6-phosphate dehydrogenase (G6PD) [46]. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.